Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2701 to 2750 of 3765 results for treatment

  1. Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after 2 or more systemic treatments (review of TA987) [ID6619]

    In development Reference number: GID-TA11823 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Vagus nerve stimulation for refractory epilepsy in children (IPG50)

    Evidence-based recommendations on vagus nerve stimulation for refractory epilepsy in children. This involves placing a device under the skin to send a burst of nerve messages through the nerve.

    Interventional procedures guidance
    Published
    24 March 2004
    View recommendations

    Sections for IPG50

  3. Medical technologies evaluation programme process guide (PMG34)

    This process guide describes how NICE selects medical technologies for development of NICE guidance. It also describes how the medical technologies advisory committee develops guidance on selected technologies routed to it

  4. Comprehensive assessment versus a brief assessment:- For people with a suspected common mental health disorder, what is the clinical and cost effectiveness of using a comprehensive assessment (conducted by mental health professional) versus a brief assessment (conducted by a paraprofessional)?

    remains about the accuracy and consequent identification of appropriate treatment by paraprofessionals in primary care. An assessment by...

    Research recommendation
    Published
    9 June 2015

  5. Pre-hospital initiation of fluid replacement therapy in trauma (TA74)

    Evidence-based recommendations on giving intravenous (IV) fluid replacement therapy for people with serious injuries before reaching hospital.

    Technology appraisal guidance
    Published
    28 January 2004
    View recommendations

    Sections for TA74

  6. Epidurals:- What is the clinical and cost effectiveness of image-guided compared with non-image-guided epidural injections for people with acute sciatica?

    notes(if applicable) Why this is important:- Epidural injection of treatments, including corticosteroids, is commonly offered to people...

    Research recommendation
    Published
    13 February 2017

  7. t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)

    NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes .

    Medtech innovation briefing
    Published
    22 September 2020

  8. Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD) (IPG297)

    Evidence-based recommendations on combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD). This involves accessing the bones of the hip and pelvis through a cut made on the thigh and correcting the deformity as much as possible.

    Interventional procedures guidance
    Published
    22 April 2009
    View recommendations

    Sections for IPG297

  9. Image-guided radiofrequency excision biopsy of breast lesions (IPG308)

    Evidence-based recommendations on image-guided radiofrequency excision biopsy of breast lesions. This involves inserting a probe that uses radiofrequency energy to cut through the breast internally, and removing the lump with a small area of surrounding tissue to test for cancer.

    Interventional procedures guidance
    Published
    22 July 2009
    View recommendations

    Sections for IPG308

  10. Care pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance misuse?

    important:- There is a lack of published evidence on care pathways on treatment, management and follow-up of people with coexisting...

    Research recommendation
    Published
    10 February 2017

  11. NICE encourages further research on laparoscopic gastric plication for severe obesity, which should include information about long-term efficacy and safety, and specifically how the procedure influences further gastric surgery. Comparison with alternative procedures would be useful.

    efficacy of the procedure. Therefore, laparoscopic gastric plication for the treatment of severe obesity should only be used with...

    Research recommendation
    Published
    9 June 2015

  12. For people with alcohol dependence, which medication is most likely to improve adherence and thereby promote abstinence and prevent relapse?

    are still clinically and cost effective. Retaining more service users in treatment could further significantly improve outcomes for...

    Research recommendation
    Published
    9 June 2015

  13. Radiofrequency ablation for the treatment of colorectal metastases in the liver (IPG92)

    This guidance has been updated and replaced by NICE interventional procedure guidance 327.

    Interventional procedures guidance
    Published
    1 September 2004

  14. Non-rigid stabilisation techniques for the treatment of low back pain (IPG183)

    This guidance has been updated and replaced by NICE interventional procedure guidance 366.

    Interventional procedures guidance
    Published
    23 June 2006

  15. Beta interferon and glatiramer acetate for the treatment of multiple sclerosis (TA32)

    This guidance has been updated and replaced by NICE technology appraisal guidance 527.

    Technology appraisal guidance
    Published
    23 January 2002

  16. Undisplaced intracapsular hip fractures: For people with undisplaced (or non-displaced) intracapsular hip fracture, what features should be used to characterise the injury and what are the optimal clinical and cost-effective management strategies?

    recognised, resulting in some people not being offered the most appropriate treatment. Research is needed to help healthcare...

    Research recommendation
    Published
    3 February 2023

  17. What is the clinical effectiveness and safety of differing doses of lipid-modifying therapy in children with FH?

    concentration in treated children with FH receiving lipid-modifying drug therapy. Treatment is recommended from 10 years onwards,...

    Research recommendation
    Published
    15 November 2019

  18. Enteral nutrition support:- What specific clinical and non-clinical factors allow risk stratification when selecting which people with CUADT would benefit from short- or long-term enteral nutrition?

    diagnosis for people who need enteral nutrition support during curative treatment. Variation across the UK exists as a result of...

    Research recommendation
    Published
    6 April 2016

  19. An instrument to measure quality of life in people with glaucoma:- What instrument should be used to measure health related quality of life in people with glaucoma?

    is important:- Quality of life is the most important overall measure of treatment effect for patients as it measures their life...

    Research recommendation
    Published
    18 October 2018

  20. Long-term outcomes of pharmacological and uterine-sparing surgical treatments for HMB associated with adenomyosis:- What are the long-term clinical outcomes of pharmacological and uterine-sparing surgical treatments in women with HMB associated with adenomyosis?

    impact of adenomyosis on symptoms of HMB or the best treatment for this condition. Optimising treatment can lead to better...

    Research recommendation
    Published
    14 November 2018

  21. Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease (IPG593)

    Evidence-based recommendations on intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure in people with motor neurone disease. This involves implanting electrodes into the diaphragm to make it contract. This gradually strengthens the diaphragm and may eventually help the person to breathe without a ventilator.

    Interventional procedures guidance
    Published
    27 September 2017
    View recommendations

    Sections for IPG593

  22. FRAX and QFracture in adults receiving bone protective therapy:- What is the utility of FRAX and QFracture in adults receiving bone protective therapy?

    at the end of this treatment period is important, since some people remain at high risk of fracture and require continued...

    Research recommendation
    Published
    9 June 2015

  23. Non-invasive tests for diagnosing NASH:- Which non-invasive tests most accurately identify non-alcoholic steatohepatitis (NASH) in people with non-alcoholic fatty liver disease (NAFLD)?

    morbidity and mortality. As a result, NASH has been the main target for treatment in NAFLD. This is because reducing the severity of...

    Research recommendation
    Published
    24 August 2016

  24. Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents (TA13)

    This guidance has been replaced by NICE technology appraisal guidance 98 [Replaced by NICE guideline NG87].  

    Technology appraisal guidance
    Published
    28 October 2000

  25. Telaprevir for the treatment of genotype 1 chronic hepatitis C (TA252)

    Telaprevir no longer has a marketing authorisation in the UK so this guidance has been withdrawn.

    Technology appraisal guidance
    Published
    25 April 2012

  26. Cetuximab for the first-line treatment of metastatic colorectal cancer (TA176)

    This guidance has been updated and replaced by NICE technology appraisal guidance 439.

    Technology appraisal guidance
    Published
    26 August 2009

  27. Erlotinib for the treatment of non-small-cell lung cancer (TA162)

    This guidance has been updated and replaced by NICE technology appraisal guidance 374.

    Technology appraisal guidance
    Last updated
    1 December 2012

  28. Bevacizumab for the first-line treatment of metastatic breast cancer (TA147)

    This appraisal has been updated and replaced by NICE technology appraisal 214.

    Technology appraisal guidance
    Published
    25 June 2008

  29. Human growth hormone for the treatment growth failure in children (TA42)

    This guidance has been updated and replaced by NICE technology appraisal guidance 188. 

    Technology appraisal guidance
    Published
    27 May 2002

  30. PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)

    We have moved Diagnostics guidance 45 to become HealthTech guidance 610. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Diagnostics guidance
    Published
    23 February 2022

  31. Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)

    We have moved medical technologies guidance 6 to become HealthTech guidance 268. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Medical technologies guidance
    Published
    25 July 2011

  32. Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death (IPG603)

    Evidence-based recommendations on subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death. This involves placing a device under the skin of the chest, which detects and treats fast heartbeats called tachyarrhythmias.

    Interventional procedures guidance
    Published
    20 December 2017
    View recommendations

    Sections for IPG603

  33. Assessing motility of the gastrointestinal tract using a wireless capsule (IPG502)

    Evidence-based recommendations on assessing motility of the gastrointestinal tract using a wireless capsule. This involves swallowing a capsule that sends bowel information as it passes through the digestive system.

    Interventional procedures guidance
    Published
    23 August 2014
    View recommendations

    Sections for IPG502

  34. Laparoscopic mobilisation of the greater omentum for breast reconstruction (IPG253)

    Evidence-based recommendations on laparoscopic mobilisation of the greater omentum for breast reconstruction. This involves removing the fatty tissue using special instruments through small cuts in the abdomen.

    Interventional procedures guidance
    Published
    27 February 2008
    View recommendations

    Sections for IPG253

  35. Laparoscopic prostatectomy for benign prostatic obstruction (IPG275)

    Evidence-based recommendations on laparoscopic prostatectomy for benign prostatic obstruction. This involves removing the prostate through small cuts in the abdomen, using a fine telescope to see inside the body (keyhole surgery).

    Interventional procedures guidance
    Published
    26 November 2008
    View recommendations

    Sections for IPG275

  36. Cyanoacrylate glue for hernia mesh fixation (MIB301)

    NICE has developed a medtech innovation briefing (MIB) on cyanoacrylate glue for hernia mesh fixation .

    Medtech innovation briefing
    Published
    5 July 2022

  37. Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula (IPG507)

    Evidence-based recommendations on insertion of a collagen plug to close an abdominal wall enterocutaneous fistula. This involves inserting a collagen plug into the fistula to seal off where it joins the bowel.

    Interventional procedures guidance
    Published
    27 November 2014
    View recommendations

    Sections for IPG507

  38. Assessment models for different groups of children and young people:- How effective are the models currently used for assessing the needs of, and level of risk for, children and young people from different population groups who display harmful sexual behaviour?

    basis for needs assessment and decisions about therapeutic interventions, treatment placements and care plans.For those in the criminal...

    Research recommendation
    Published
    17 October 2016

  39. How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period?

    explanatory notes(if applicable) Drugs are effective for the acute treatment of bipolar disorder and for preventing relapse. All drugs...

    Research recommendation
    Published
    13 July 2017

  40. Cystourethrogram: How accurate is the first CT scan with contrast (trauma scan) for detecting bladder injuries in people with suspected bladder injuries after a traumatic incident?

    diagnose non‑bladder injuries. People who do not have injuries needing urgent treatment may then either be given another CT scan or a...

    Research recommendation
    Published
    12 December 2022

  41. Cystourethrogram:- How accurate is the first CT scan with contrast (trauma scan) for detecting bladder injuries in people with suspected bladder injuries after a traumatic incident?

    diagnose non-bladder injuries. People who do not have injuries needing urgent treatment may then either be given another CT scan or a...

    Research recommendation
    Published
    21 March 2016

  42. Primary versus secondary stenting for treating people with critical limb ischaemia caused by disease of the infra-geniculate arteries:- What is the clinical and cost effectiveness of selective stent placement compared with angioplasty plus primary stent placement for treating people with critical limb ischaemia caused by disease of the infra-geniculate arteries?

    endovascular treatment. Infra-geniculate disease is more complex to treat by endovascular means, and the risks and benefits of different...

    Research recommendation
    Published
    9 June 2015

  43. Current evidence on the safety and efficacy of valve-in-valve transcatheter aortic valve implantation (ViV‑TAVI) for aortic bioprosthetic dysfunction is adequate to support the use of this procedure provided that  standard arrangements   are in place for clinical governance, consent and audit.

    them. During the consent process, patients should be told about all treatment options, and their advantages and disadvantages. ViV‑TAVI...

    Research recommendation
    Published
    22 June 2023

  44. Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (HTG530)

    Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are ABL800 FLEX, i-STAT Alinity and StatSensor, ABL90 FLEX PLUS, Dri chem NX500, epoc Blood Analysis System, and Piccolo Xpress.

    HealthTech guidance
    Published
    13 November 2019
    View recommendations

    Sections for HTG530

  45. Pressure ulcers (QS89)

    This quality standard covers preventing, assessing and managing pressure ulcers (bed sores) in adults, young people and children. It includes risk assessment and support to prevent pressure ulcers. It applies to all settings, including hospitals, care homes (with and without nursing care) and people’s own homes.

    Quality standard
    Published
    11 June 2015
    View quality statements

    Sections for QS89

  46. Percutaneous endoscopic laser thoracic discectomy (IPG61)

    Evidence-based recommendations on percutaneous endoscopic laser thoracic discectomy. This involves using a laser to heat and destroy some of the inside of the disc and shrink the part that is sticking out.

    Interventional procedures guidance
    Published
    27 May 2004
    View recommendations

    Sections for IPG61

  47. Therapeutic percutaneous image-guided aspiration of spinal cysts (IPG223)

    Evidence-based recommendations on therapeutic percutaneous image-guided aspiration of spinal cord cysts. This involves using a needle to drain the cyst and remove pressure on the spinal cord or nerve roots.

    Interventional procedures guidance
    Last updated
    1 August 2007
    View recommendations

    Sections for IPG223

  48. Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) (IPG188)

    Evidence-based recommendations on deep brain stimulation for tremor and dystonia (excluding Parkinson's disease). This involves planting electrodes in the brain and generating electrical currents to help control the tremor or dystonia.

    Interventional procedures guidance
    Published
    23 August 2006
    View recommendations

    Sections for IPG188

  49. Paige Prostate for prostate cancer (MIB280)

    NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer .

    Medtech innovation briefing
    Published
    30 November 2021

  50. Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation